Variant report
Variant | esv1838593 |
---|---|
Chromosome Location | chr10:56446495-56469288 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139946609 | chr10:56448606-56448607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181341434 | chr10:56448653-56448654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139823516 | chr10:56448728-56448729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149784089 | chr10:56448780-56448781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377468568 | chr10:56448808-56448809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185559741 | chr10:56448869-56448870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557023909 | chr10:56448883-56448884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16906408 | chr10:56448886-56448887 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs189099796 | chr10:56448904-56448905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553064387 | chr10:56448932-56448933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573516066 | chr10:56448979-56448980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545356357 | chr10:56448990-56448991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534587088 | chr10:56449057-56449058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565520825 | chr10:56449071-56449072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575901000 | chr10:56449087-56449088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544778421 | chr10:56449102-56449103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528320301 | chr10:56449160-56449161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560971034 | chr10:56449197-56449198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529788883 | chr10:56449246-56449247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557754811 | chr10:56449274-56449275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559874730 | chr10:56449275-56449276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181437981 | chr10:56449335-56449336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577832959 | chr10:56449346-56449347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186067448 | chr10:56449363-56449364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145697499 | chr10:56449382-56449383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141681980 | chr10:56449395-56449396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376050783 | chr10:56449396-56449397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115145945 | chr10:56449425-56449426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536333341 | chr10:56449439-56449440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192455853 | chr10:56449452-56449453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183789577 | chr10:56449467-56449468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539361406 | chr10:56449480-56449481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546496779 | chr10:56449497-56449498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564926077 | chr10:56449672-56449673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559304329 | chr10:56449675-56449676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147066282 | chr10:56449686-56449687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114082012 | chr10:56449714-56449715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377491916 | chr10:56449755-56449756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565286370 | chr10:56449759-56449760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574616052 | chr10:56449809-56449810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529629987 | chr10:56449868-56449869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368834452 | chr10:56449873-56449874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186180969 | chr10:56449921-56449922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71461252 | chr10:56449922-56449923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560138272 | chr10:56449923-56449924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532000233 | chr10:56449931-56449932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545742637 | chr10:56449960-56449961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562445701 | chr10:56449961-56449962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201733434 | chr10:56449962-56449963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147685429 | chr10:56450031-56450032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56448600-56449000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr10:56449000-56451000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr10:56450200-56452800 | Enhancers | Fetal Lung | lung |
4 | chr10:56450800-56451600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr10:56451000-56451600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr10:56451200-56451600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr10:56458000-56459000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr10:56466400-56471000 | Enhancers | Fetal Lung | lung |
9 | chr10:56466600-56469000 | Enhancers | Fetal Brain Male | brain |
10 | chr10:56467600-56468800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr10:56468600-56469200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr10:56469200-56470600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |